Countermeasures for sleep loss and deprivation

Current Treatment Options in Neurology

Volumn 8, Issue 5, 2006, Pages 361-366

  Kushida, Clete A ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CLONIDINE; COUMARIN; DEXAMPHETAMINE; DEXTROPROPOXYPHENE; ETHOSUXIMIDE; GUANETHIDINE; HALOPERIDOL; LITHIUM CARBONATE; METHAMPHETAMINE; METHENAMINE; METHYLPHENIDATE; MODAFINIL; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PEMOLINE; PETHIDINE; PHENOBARBITAL; PHENYLBUTAZONE; PHENYTOIN; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERATRUM ALKALOID;

ALERTNESS; ANOREXIA; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUDITORY STIMULATION; BODY WEIGHT DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DAYTIME SOMNOLENCE; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DRUG CONTRAINDICATION; DRUG DEPENDENCE; DRUG INDUCED HEADACHE; DYSKINESIA; DYSPHORIA; EUPHORIA; EXERCISE; GASTROINTESTINAL TOXICITY; GILLES DE LA TOURETTE SYNDROME; HEART PALPITATION; HUMAN; HYPERTENSION; IMPOTENCE; INFECTION; INSOMNIA; LIBIDO DISORDER; LIVER FAILURE; MENTAL OVERSTIMULATION; NARCOLEPSY; NERVOUSNESS; NIGHT WORK; RESTLESSNESS; REVIEW; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP WAKING CYCLE; TACHYCARDIA; TASTE DISORDER; TIC; TREMOR; URTICARIA; WAKEFULNESS; WEIGHT REDUCTION; XEROSTOMIA;

EID: 33748486691     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0025-7     Document Type: Review

References (11)

1. Chen W, Kushida CA: Perspectives. In Sleep Deprivation: Basic Science, Physiology, and Behavior. Edited by Kushida CA New York: Marcel Dekker; 2005:1-30.
2. Kushida CA: Sleep Deprivation: Basic Science, Physiology, and Behavior. New York: Marcel Dekker; 2005.
3. Kushida CA: Sleep Deprivation: Clinical Issues, Pharmacology, and Sleep Loss Effects. New York: Marcel Dekker; 2005.
4. Bonnet MH, Arand DL: We are chronically sleep deprived. Sleep 1995, 18:908-911.
5. Caldwell JA, Caldwell JL: Stimulants. In Sleep Deprivation: Clinical Issues, Pharmacology, and Sleep Loss Effects. Edited by Kushida CA. New York: Marcel Dekker; 2005:387-446.
6. Schweitzer PK, Randazzo AC, Stone K, et al.: Laboratory and field studies of naps and caffeine as practical countermeasures for sleep-wake problems associated with night work. Sleep 2006, 29:39-50.
7. Brooks A, Lack L: Naps. In Sleep Deprivation: Basic Science, Physiology, and Behavior. Edited by Kushida CA. New York: Marcel Dekker; 2005:457-474.
8. Heslegrave RJ, Angus RG: The effects of task duration and work-session location on performance degradation induced by sleep loss and sustained cognitive work. Behav Res Methods Instrum Comput 1985, 17:592-603.
9. Pigeau R, Naitoh P, Buguet A, et al.: Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. 1. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995, 4:212-228.
10. Bonnet MH, Arand DL: Sleepiness as measured by modified multiple sleep latency testing varies as a function of preceding activity. Sleep 1998, 21:477-483.
11. Roehrs T, Roth T: Behavioral and environmental countermeasures. In Sleep Deprivation: Clinical Issues, Pharmacology, and Sleep Loss Effects. Edited by Kushida CA. New York: Marcel Dekker; 2005:447-456.